Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Blood|November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host diseaseKathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Transplantation and Cellular Therapy|May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host DiseaseZhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemiaJennifer R Brown, Haesook T Kim, Shuli Li, et al.
Blood|December 23, 2004
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remissionDavid B Miklos, Haesook T Kim, Katherine H Miller, et al.
Science Translational Medicine|April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host diseaseKen-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood|January 24, 2012
Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantationMelinda A Biernacki, Yu-tzu Tai, Guang Lan Zhang, et al.
Cancer Research|February 4, 2010
Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigensOvidiu Marina, Ursula Hainz, Melinda A Biernacki, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2014
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)Jan H Beumer, Kouros Owzar, Lionel D Lewis, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Blood|November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host diseaseKathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Transplantation and Cellular Therapy|May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host DiseaseZhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemiaJennifer R Brown, Haesook T Kim, Shuli Li, et al.
Blood|December 23, 2004
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remissionDavid B Miklos, Haesook T Kim, Katherine H Miller, et al.
Science Translational Medicine|April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host diseaseKen-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood|January 24, 2012
Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantationMelinda A Biernacki, Yu-tzu Tai, Guang Lan Zhang, et al.
Cancer Research|February 4, 2010
Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigensOvidiu Marina, Ursula Hainz, Melinda A Biernacki, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2014
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)Jan H Beumer, Kouros Owzar, Lionel D Lewis, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Pageof 18